Octagon Capital Advisors

Latest statistics and disclosures from Octagon Capital Advisors's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Octagon Capital Advisors

Companies in the Octagon Capital Advisors portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Apellis Pharmaceuticals (APLS) 10.9 $31M 548k 57.20
I Mab Sponsored Ads (IMAB) 7.4 $21M 455k 47.15
Celldex Therapeutics Com New (CLDX) 6.3 $18M 1.0M 17.52
Curis Com New (CRIS) 6.2 $18M 2.2M 8.19
4d Molecular Therapeutics In (FDMT) 5.4 $16M 378k 41.45
Pmv Pharmaceuticals (PMVP) 5.3 $15M 250k 61.51
Arvinas Ord (ARVN) 5.3 $15M 179k 84.93
Gossamer Bio (GOSS) 5.2 $15M 1.6M 9.67
Acceleron Pharma (XLRN) 5.0 $14M 112k 127.94
Chemocentryx (CCXI) 4.8 $14M 225k 61.92
Cardiff Oncology (CRDF) 4.1 $12M 650k 17.99
Avidity Biosciences Ord (RNA) 3.8 $11M 430k 25.52
Dyne Therapeutics (DYN) 3.5 $10M 482k 21.00
Taysha Gene Therapies Com Shs (TSHA) 2.9 $8.5M 320k 26.54

Setup an alert

Octagon Capital Advisors will file the next quarterly 13-HR in about 1 months. Would you like to be notified?

Arcus Biosciences Incorporated (RCUS) 2.7 $7.8M 300k 25.96
Calliditas Therapeutics Ab Sponsered Ads (CALT) 2.3 $6.7M 200k 33.62
Fibrogen (FGEN) 1.9 $5.4M 146k 37.09
Kiniksa Pharmaceuticals Com Cl A (KNSA) 1.8 $5.2M 295k 17.67
Revolution Medicines (RVMD) 1.7 $5.0M 126k 39.59
Kura Oncology (KURA) 1.7 $4.9M 150k 32.66
Iveric Bio (ISEE) 1.6 $4.7M 680k 6.91
Helix Acquisition Corp Com Cl A (HLXA) 1.6 $4.5M 400k 11.37
Kronos Bio (KRON) 1.5 $4.4M 146k 29.87
Jiya Acquisition Corp Com Cl A (JYAC) 1.1 $3.1M 300k 10.30
Viela Bio 1.1 $3.1M 85k 35.97
Inventiva Sa Ads (IVA) 1.0 $2.9M 200k 14.50
Arcutis Biotherapeutics (ARQT) 1.0 $2.8M 100k 28.13
Ngm Biopharmaceuticals (NGM) 0.8 $2.3M 75k 30.30
Aclaris Therapeutics (ACRS) 0.8 $2.3M 350k 6.47
Kadmon Hldgs (KDMN) 0.6 $1.8M 434k 4.15
Axsome Therapeutics (AXSM) 0.6 $1.6M 20k 81.45

Past Filings by Octagon Capital Advisors

SEC 13F filings are viewable for Octagon Capital Advisors going back to 2020